Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 December 2022 | Story Gerda-Marié van Rooyen | Photo Supplied
Olebogeng TIhong
Olebogeng TIhong loves stages and cameras. She is currently studying law.

An ex-CyberSta presenter has recently made her soap debut in The River.

Olebogeng Tlhong, a fourth-year LLB student at the UFS, recently portrayed the part of a celebrity, something she says works perfectly with her personality. However, acting is only one of her many gifts and interests.

She also owns an enterprise. “I established my online store in 2020 during the COVID-19 pandemic and registered my company in October 2021.” This company, a segment of Greys World, consists of an events company, bikini line, cosmetics and accessory stores and a clothing aspect.

Passionate about the entertainment space

This born Johannesburger describes herself as a “vibrant, hard-working, resilient and multifaceted woman who loves life and all that it has to offer”. Confidence is something she has in ample supply. “I have always been a confident individual. I have participated in public-speaking competitions from a young age. I am passionate about the entertainment space.” She loves people too. "I draw inspiration from different people for different reasons and aspects of my life. This includes from the women in my family to service workers’ stories, celebrity figures and the teachings of Christ.” 

Visualisation is something this entertainer strongly believes in. “The kind of life that I envision for myself, inspires me. I want to own my time and live on my terms. Having a vision board and holding myself accountable has played a large role in ensuring that I execute everything that I said I would. I believe in being proactive and solution based.” 

Crossing boundaries and achieving dreams

Olebogeng dreams of leaving a legacy echoing her courage to cross boundaries and achieve her dreams. “I want people to draw inspiration from me and know that they can achieve anything – regardless of obstacles or one’s past. One can build an empire from nothing,” says this wanna-be world traveller.

While it is uncertain where Olebogeng’s river will take her, one thing is certain, she’ll always seize the day. “I want to remain teachable to grow. The aim is to never get comfortable and to keep striving for more.”

 


 

Olebogeng appeared on The River, episode 240, that aired beginning/mid-October.

 


 

This guest appearing actress has always been confident. “I used to participate in public speaking competitions from a young age and I love the entertainment space.”

 


 

“Enjoy university, meet new people and grab every opportunity that aligns with your purpose, have fun and most importantly, ensure that your academics are always in order,” Olebogeng advises the first-year students of 2023.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept